Cite
HARVARD Citation
Sadredini, M. et al. (2021). CaMKII as a therapeutic target in catecholaminergic polymorphic ventricular tachycardia type 1. Europace. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sadredini, M. et al. (2021). CaMKII as a therapeutic target in catecholaminergic polymorphic ventricular tachycardia type 1. Europace. p. . [Online].